Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_provenance.
- NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_assertion description "[The most important serological markers reflect the tumor load (beta-2 microglobulin, beta 2-M), proliferative activity (lactic dehydrogenase, LDH), and invasive potential of lymphomas (CA 125).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_provenance.
- NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_assertion evidence source_evidence_literature NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_provenance.
- NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_assertion SIO_000772 10569136 NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_provenance.
- NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_assertion wasDerivedFrom befree-2016 NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_provenance.
- NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_assertion wasGeneratedBy ECO_0000203 NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_provenance.
- befree-2016 importedOn "2016-02-19" NP268077.RAx0_51Tz0D0g0HxD5GRRN18bZqXtp3QdMlCniMlqE-u8130_provenance.